| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 123 |
| 1 | DEXAMETHASONE | 107 |
| 2 | ASPIRIN | 106 |
| 3 | DEXAMETHASONE 1.5 MG | 104 |
| 4 | ASPIRIN 325 MG | 103 |
| 5 | ASPIRIN 81 MG | 103 |
| 6 | BEVACIZUMAB | 94 |
| 7 | LENALIDOMIDE | 93 |
| 8 | ADALIMUMAB | 91 |
| 9 | METHOTREXATE SODIUM | 90 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUINIDINE SULFATE TABLET | 13 | 0.0903 |
| 1 | PROCAINAMIDE HYDROCHLORIDE | 16 | 0.0648 |
| 2 | CHLORPROMAZINE HYDROCHLORIDE | 10 | 0.0105 |
| 3 | BENZETHONIUM CHLORIDE | 1 | 0.0078 |
| 4 | MENADIONE | 1 | 0.0072 |
| 5 | DEXTROSE AND SODIUM CHLORIDE | 1 | 0.0060 |
| 6 | EUCALYPTOL, MENTHOL, METHYL SALICYLATE, THYMOL | 1 | 0.0042 |
| 7 | DAPRODUSTAT | 8 | 0.0040 |
| 8 | NAFARELIN ACETATE | 1 | 0.0037 |
| 9 | HYDRALAZINE HYDROCHLORIDE | 9 | 0.0034 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 302 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 203 |
| 2 | Factor Xa Inhibitor [EPC] | 130 |
| 3 | Platinum-based Drug [EPC] | 128 |
| 4 | Proton Pump Inhibitor [EPC] | 124 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 107 |
| 6 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 99 |
| 7 | Thalidomide Analog [EPC] | 94 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 91 |
| 9 | Benzodiazepine [EPC] | 84 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 8 | 0.0035 |
| 1 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 2 | Sclerosing Agent [EPC] | 1 | 0.0022 |
| 3 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 4 | Anti-coagulant [EPC] | 6 | 0.0016 |
| 5 | Allylamine Antifungal [EPC] | 8 | 0.0011 |
| 6 | Thrombopoietin Receptor Agonist [EPC] | 15 | 0.0010 |
| 7 | Methylating Agent [EPC] | 1 | 0.0010 |
| 8 | Gonadotropin [EPC] | 2 | 0.0009 |
| 9 | Typical Antipsychotic [EPC] | 22 | 0.0009 |